Article

Adherence to and optimization of guidelines for Risk of Recurrence/Prosigna testing using a machine learning model: a Swedish multicenter study

2024-03-19

Abstract excerpt

<title>Abstract</title> <p>Purpose Gene expression profiles are used for decision making in the adjuvant setting of hormone receptor positive, HER2 negative (HR+/HER2-) breast cancer. Previous studies have reported algorithms to optimize the use of RS/Oncotype Dx but no such efforts have focused on ROR/Prosigna. We sought to improve pe-selection of patients before testing using machine learning. Methods Postmen...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f24d1c38-7b76-5370-8824-d754269bc568
DOI: 10.21203/rs.3.rs-4110196/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Adherence to and optimization of guidelines for Risk of Recurrence/Prosigna testing using a machine learning model: a Swedish multicenter studyDOI 10.21203/rs.3.rs-4110196/v1Read

Evaluation and comparison of different breast cancer prognosis scores based on gene expression dataSemantic proximity Read

High concordance of 70-gene recurrence risk signature and 80-gene molecular subtyping signature between core needle biopsy and surgical resection specimens in early-stage breast cancerSemantic proximity Read

Clinical evaluation of deep learning-based risk profiling in breast cancer histopathology and comparison to an established multigene assaySemantic proximity Read

Evaluation and comparison of different breast cancer prognosis scores based on gene expression dataSemantic proximity Read

Multimodal histopathologic models stratify hormone receptor-positive early breast cancerSemantic proximity Read

Breast medical oncologists' use of standard prognostic factors to predict a 21-gene recurrence score.Semantic proximity Read

Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutations.Semantic proximity Read

Bridging and analytical validation of the Prosigna <sup>®</sup> Breast Risk of Recurrence Test as a whole-transcriptome NGS lab developed testSemantic proximity Read

Evaluation of an AI-Based Digital Pathology Tool for Breast Cancer Recurrence RiskSemantic proximity Read

A Nomogram for Predicting Mammaprint Results in Women with T1-3N0-1M0 Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor-2-Negative Breast CancerSemantic proximity Read

Predicting Breast Cancer Prognosis Using PR and PIK3CA Biomarkers: A Comparative Analysis of Diagnostic GroupsSemantic proximity Read